Kimberly-Clark said Monday it would acquire Kenvue for more than $40 billion in cash and stock, creating a consumer powerhouse uniting brands like Huggies and Kleenex with names like Band-Aid and Tylenol.
Why it matters: It’s a major gamble for Kimberly-Clark, given that Kenvue’s Tylenol is currently under a Trump administration microscope over alleged links to autism, which the company fervently denies.